Compare · NAKA vs OPCH
NAKA vs OPCH
Side-by-side comparison of Nakamoto Inc. (NAKA) and Option Care Health Inc. (OPCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NAKA and OPCH operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.15B, about 38.7x NAKA ($81.4M).
- Over the past year, NAKA is down 99.1% and OPCH is down 36.6% - OPCH leads by 62.5 points.
- OPCH has been more active in the news (13 items in the past 4 weeks vs 8 for NAKA).
- OPCH has more recent analyst coverage (15 ratings vs 3 for NAKA).
- Company
- Nakamoto Inc.
- Option Care Health Inc.
- Price
- $4.67+8.74%
- $20.07-2.00%
- Market cap
- $81.4M
- $3.15B
- 1M return
- -35.32%
- -3.28%
- 1Y return
- -99.13%
- -36.63%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- News (4w)
- 8
- 13
- Recent ratings
- 3
- 15
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
Latest NAKA
- Amendment: SEC Form SCHEDULE 13D/A filed by Nakamoto Inc.
- Nakamoto Chairman and CEO David Bailey Purchases Additional Shares of Common Stock
- Chief Executive Officer Bailey David F bought $309,516 worth of shares (55,115 units at $5.62), increasing direct ownership by 2% to 3,175,476 units (SEC Form 4)
- Chief Executive Officer Bailey David F bought $683,112 worth of shares (136,333 units at $5.01), increasing direct ownership by 5% to 3,120,361 units (SEC Form 4)
- Nakamoto Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Nakamoto Announces Expansion of Board of Directors
- Bitcoin for Corporations to Host the First Dedicated Institutional Bitcoin Symposium in New York City
- Following Stockholder Approval, Nakamoto Announces 1-for-40 Reverse Stock Split to be Effective on May 22, 2026
- Amendment: SEC Form SCHEDULE 13G/A filed by Nakamoto Inc.
- Nakamoto Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest OPCH
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
- Director Pate R Carter was granted 8,997 shares, increasing direct ownership by 77% to 20,620 units (SEC Form 4)
- Director Sullivan Timothy P was granted 13,833 shares, increasing direct ownership by 19% to 87,216 units (SEC Form 4)
- Director Bodem Barbara W. was granted 8,997 shares, increasing direct ownership by 74% to 21,087 units (SEC Form 4)
- Director Wright Norman L. was granted 8,997 shares, increasing direct ownership by 58% to 24,498 units (SEC Form 4)